Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-03-06
1999-02-09
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530306, 530324, A61K 3800, C07K 1400
Patent
active
058694501
ABSTRACT:
Peptide analogues are provided with amino acid sequences of the corticotropin-releasing factor superfamily, but having at least one amino acid residue that has been replaced with a D-amino acid residue or a D-amino acid analog. The peptide analogues have anti-inflammatory activity while having a receptor selectivity and thus a disassociated ACTH response.
REFERENCES:
patent: 4801612 (1989-01-01), Wei et al.
patent: 5112809 (1992-05-01), Rivier et al.
patent: 5137871 (1992-08-01), Wei
patent: 5177060 (1993-01-01), Wei
patent: 5306710 (1994-04-01), Wei
patent: 5374621 (1994-12-01), Wei
patent: 5480869 (1996-01-01), Wei et al.
patent: 5488033 (1996-01-01), Wei
Chen et al., "Corticotropin Releasing Factor Receptor-Mediated Stimulation of Adenylate Cyclase Activity in the Rat Brain," Brain Research, 381:1, pp. 49-57 (Aug. 1986).
Sutton et al., Endocrinology 136 No. 3 pp. 1097-1101 (Mar. 1995).
Behan et al., "Displacement of Corticotropin Releasing Factor from its Binding Protein as a Possible Treatment for Alzheimer's Disease," Nature, 378, pp. 284-286 (1995).
Kishimoto et al., "A Sauvagine/Corticotropin-Releasing Factor Receptor Expressed in Heart and Skeletal Muscle," Proc. Natl. Acad. Sci. USA, 92, pp. 1108-1112 (1995).
Kornreich et al., "Alanine Series of Ovine Corticotropin Releasing Factor (oCRF): A Structure-Activity Relationship Study," J. Med. Chem., 35, pp. 1870-1876 (1992).
Lightman, Stafford L., "From Stress to Cognition," Nature, 378, pp. 233-234 (1995).
Rivier et al., "Single Point D-Substituted Corticotropin-Releasing Factor Analogues: Effects on Potency and Physicochemical characteristics," J. Med. Chem., 6, pp. 2851-2859 (1993).
Sutton et al., "Ligand Requirements of the Human Corticotropin-Releasing Factor-Binding Protein," Endocrinology, 136:3, pp. 1097-1102 (1995).
Vaughan et al., "Urocortin, a Mammalian Neuropeptide Related to Fish Urotensin I and to Corticotropin-Releasing Factor," Nature, 378, pp. 287-292 (1995).
Wei and Kiang, "Peptides of the Corticoliberin Superfamily Attenuate Thermal and Neurogenic Inflammation in Rat Pawskin," Eur. J. Pharmacol., 68, pp. 81-86 (1989).
Wei and Thomas, "Correlation of Neuroendocrine and Anti-Edema Activities of Alanine-Corticotropin-Releasing Factor Analogs," Eur. J. Pharmacol., 263, pp. 319-321 (1994).
Kishimoto Toshimitsu
Thomas Holly A.
Wei Edward T.
Celsa Bennett
The Regents of the University of California
Tsang Cecilia J.
LandOfFree
Anti-inflammatory compositions and method with corticotropin-rel does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory compositions and method with corticotropin-rel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory compositions and method with corticotropin-rel will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1948470